NIRAVI

Serial Number 90004908
Registration 6302871
700

Registration Progress

Application Filed
Jun 16, 2020
Under Examination
Dec 22, 2020
Approved for Publication
Oct 27, 2020
Published for Opposition
Oct 27, 2020
Registered
Mar 23, 2021

Trademark Image

NIRAVI

Basic Information

Serial Number
90004908
Registration Number
6302871
Filing Date
June 16, 2020
Registration Date
March 23, 2021
Published for Opposition
October 27, 2020
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
Mar 23, 2021
Registration
Registered
Classes
005

Rights Holder

Sparsha Pharma USA, Inc.

03
Address
3919 Oceanic Drive
Oceanside, CA 92056

Ownership History

Sparsha Pharma USA, Inc.

Original Applicant
03
Oceanside, CA

Sparsha Pharma USA, Inc.

Owner at Publication
03
Oceanside, CA

Sparsha Pharma USA, Inc.

Original Registrant
03
Oceanside, CA

Legal Representation

Attorney
Gary Brenner

USPTO Deadlines

Next Deadline
498 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2021-03-23)
Due Date
March 23, 2027
Grace Period Ends
September 23, 2027
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

15 events
Date Code Type Description Documents
Mar 23, 2021 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Feb 16, 2021 SUNA E NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED Loading...
Feb 15, 2021 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED Loading...
Jan 26, 2021 SUPC I STATEMENT OF USE PROCESSING COMPLETE Loading...
Jan 25, 2021 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Jan 5, 2021 IUAF S USE AMENDMENT FILED Loading...
Jan 5, 2021 EISU I TEAS STATEMENT OF USE RECEIVED Loading...
Dec 22, 2020 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Oct 27, 2020 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Oct 27, 2020 PUBO A PUBLISHED FOR OPPOSITION Loading...
Oct 7, 2020 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Sep 18, 2020 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Sep 17, 2020 DOCK D ASSIGNED TO EXAMINER Loading...
Jul 15, 2020 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Jun 19, 2020 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Transdermal patches featuring lidocaine
First Use Anywhere: Aug 11, 2020
First Use in Commerce: Aug 11, 2020

Classification

International Classes
005